NIH-funded research R01 grant

Creating a mouse model to study Kaposi Sarcoma

Official title: PQ6: Transgenic Mouse Model for Kaposi Sarcoma

Funded at Univ of North Carolina Chapel Hill · NIH-10783749 · Data updated 2026-11-12

This study is creating special mice to help us learn more about Kaposi Sarcoma, a cancer that affects people with HIV/AIDS, so we can better understand how it develops and find new treatments that might help patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMarch 1, 2020
Project endFebruary 28, 2026
Funding year2024
Award (this year)$492,087
NIH project number5R01CA250080-05
Project IDNIH-10783749 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV/AIDS who are at risk for developing Kaposi Sarcoma.

Less likely to help

Patients with other types of cancer unrelated to Kaposi Sarcoma may not receive any benefit from this research.

What this research studies

This research focuses on developing a new transgenic mouse model to better understand Kaposi Sarcoma (KS), a common cancer in individuals with HIV/AIDS. By inserting the complete genome of the KS-associated herpesvirus (KSHV) into these mice, researchers aim to observe how KS tumors form and progress. The study will also explore potential drug treatments for KS using this model, providing insights into the disease's mechanisms and therapeutic options. Patients may benefit from the findings as they could lead to improved treatment strategies for KS.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for Kaposi Sarcoma, improving outcomes for patients affected by this cancer.

How similar studies have gone: While there have been various approaches to studying Kaposi Sarcoma, the development of a comprehensive transgenic mouse model specifically for this cancer is a novel endeavor.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Dittmer, Dirk P — Univ of North Carolina Chapel Hill
  • Study coordinator: Dittmer, Dirk P

Related research

Other NIH-funded projects on the same topics.

  • Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D

    A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.

    NIH research Washington University · Saint Louis, United States · NIH-11535366

  • Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D

    A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.

    NIH research Washington University · Saint Louis, United States · NIH-11535365

  • Kaposi Sarcoma care and research in Africa during ART era

    A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11535231

  • Kaposi Sarcoma in Africa: ART Era Research Network

    A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11535230

  • Kaposi Sarcoma in Africa in the ART Era

    This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11417959

  • Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa

    This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11416376

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.